Juvederm Voluma XC, the latest treatment from Allergan, targets lack of volume and sagging skin to offer a subtle lift to the face. Juvederm Voluma XC is the first and only FDA-approved filler for adding volume to the cheek area. The injectable gel formula uses hyaluronic acid, a substance that occurs naturally in the skin, and requires little to no downtime.
- Juvéderm Voluma XC was approved by the U.S. Food and Drug Administration in December as the first injectable filler to instantly add volume to the cheek area.
- Juvederm Voluma lasts longer. Clinical studies are showing that Juvederm Voluma lasts about two years as opposed to the 12-18 months of Radiesse.
- The XC in Juvederm XC indicates that the filler contains lidocaine in the syringe, which makes it much more comfortable for you, the patient.
BEFORE/AFTER
TREATMENT VIDEO
TREAT EARLY SIGNS OF AGING ON MEN
A well-performed surgical facelift actually repositions the cheek fat that sags as a result of gravity over time. As an injectable, Juvederm Voluma can’t reposition cheek fat, but its thicker, cross-linked formula adds volume in a way that restores a more youthful contour to the midface.
This subtle lift achieved with Juvederm Voluma XC can make a dramatic difference as clients surveyed in past clinical trials said they looked up to 5 years younger with results lasting up to 2 years. A side-benefit of restoring volume to the cheek area is that it can also improve wrinkles and lines in other areas of the face, particularly the nasolabial folds and the area around the eyes. These results vary from patient to patient depending on the depth and location of the wrinkles.
